226 related articles for article (PubMed ID: 805659)
41. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
42. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
HarĊozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
[TBL] [Abstract][Full Text] [Related]
43. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
[TBL] [Abstract][Full Text] [Related]
44. Fine needle aspiration of cystic liver lesions. Cytologic examination and carcinoembryonic antigen assay of cyst contents.
Pinto MM; Kaye AD
Acta Cytol; 1989; 33(6):852-6. PubMed ID: 2686325
[TBL] [Abstract][Full Text] [Related]
45. [Immunochemical identification of carcinoembryonic antigen in ovarian adenocarcinoma and pseudomucinous cystoma extracts].
Tatarinov IuS; Kalashnikov VV; Borisenko SA; Griaznova IM; Vasil'eva NN
Biull Eksp Biol Med; 1975 Jan; 79(1):50-3. PubMed ID: 803383
[TBL] [Abstract][Full Text] [Related]
46. An antiserum to ovarian mucinous cyst fluid with colon cancer specificity.
McNeil C; Ladle JN; Helmick WM; Trentelman E; Wentz MW
Cancer Res; 1969 Aug; 29(8):1535-40. PubMed ID: 4308954
[No Abstract] [Full Text] [Related]
47. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
48. Cystadenocarcinoma and carcinoembryonic antigen (CEA).
Ferrer JP; Hensley G; Kalser MH; Zeppa R
Cancer; 1978 Aug; 42(2):632-4. PubMed ID: 679155
[TBL] [Abstract][Full Text] [Related]
49. Detection of tumor-specific antigens in human mucinous cystadenocarcinoma of the ovary by immunodiffusion.
Chow SN; Chiang WT; Wei PY
Int J Gynaecol Obstet; 1976; 14(3):280-4. PubMed ID: 13019
[TBL] [Abstract][Full Text] [Related]
50. Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.
Pattillo RA; Story MT; Ruckert AC
Cancer Res; 1979 Apr; 39(4):1185-92. PubMed ID: 421202
[TBL] [Abstract][Full Text] [Related]
51. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
52. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
Wu JT; Miya T; Knight JA; Knight DP
Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
[TBL] [Abstract][Full Text] [Related]
53. Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
Pinto MM; Bernstein LH; Brogan DA; Parikh F; Lavy G
Diagn Cytopathol; 1990; 6(3):160-3. PubMed ID: 1696873
[TBL] [Abstract][Full Text] [Related]
54. Ovarian tumor-specific antigens.
Knauf S; Urbach GI
Am J Obstet Gynecol; 1974 Aug; 119(7):966-70. PubMed ID: 4135399
[No Abstract] [Full Text] [Related]
55. Immunoradiometric assay of CA 125 in effusions. Comparison with carcinoembryonic antigen.
Pinto MM; Bernstein LH; Brogan DA; Criscuolo E
Cancer; 1987 Jan; 59(2):218-22. PubMed ID: 3467816
[TBL] [Abstract][Full Text] [Related]
56. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations.
van Nagell JR; Donaldson ES; Gay EC; Sharkey RM; Rayburn P; Goldenberg DM
Cancer; 1978 Jun; 41(6):2335-40. PubMed ID: 350376
[No Abstract] [Full Text] [Related]
57. [Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma].
Sakayori M; Nozawa S; Udagawa Y; Chin K; Lee SG; Sakuma T; Iizuka R; Wada Y; Yoshida S; Takeda Y
Hum Cell; 1990 Mar; 3(1):52-6. PubMed ID: 2083224
[TBL] [Abstract][Full Text] [Related]
58. [The carcinoembryonic antigen (CEA) in bronchial carcinoma before and after operation (author's transl)].
Euler EC; Euler HH; Ammedick U; Konrad RM; Vollmer UJ
Thoraxchir Vask Chir; 1978 Apr; 26(2):65-9. PubMed ID: 77567
[TBL] [Abstract][Full Text] [Related]
59. Peripheral and ovarian venous concentrations of gonadal steroids and CEA in women with ovarian tumors.
Jeppsson S; Kullander S; Rannevik G
Acta Obstet Gynecol Scand; 1982; 61(3):209-12. PubMed ID: 6812383
[No Abstract] [Full Text] [Related]
60. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
Heald J; Buckley CH; Fox H
J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
